Jeff Baxter
Chief Executive Officer at VBI VACCINES INC.
Net worth: 12 144 $ as of 29/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert Fried | M | 64 | 9 years | |
Steven Rubin | M | 63 | 12 years | |
Steven Gillis | M | 71 |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014.
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | 19 years |
Athena Kartsaklis | F | 59 | 7 years | |
Nell Beattie | F | 36 | 9 years | |
Michel de Wilde | M | 74 |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | 10 years |
Scott Requadt | M | 56 |
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | 4 years |
Francisco Diaz-Mitoma | M | 69 |
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | 17 years |
Nicole Anderson | F | - | 7 years | |
Misha Nossov | M | - | 14 years | |
Joanne Cordeiro | F | 66 | 5 years | |
Wing Tak Yu | F | 48 | 7 years | |
Gary Ng | M | 52 | 3 years | |
Blaine McKee | M | 59 | 5 years | |
Vaughn Himes | M | 63 | 1 years | |
David Anderson | M | 54 |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | 9 years |
Damian Braga | M | 68 | 4 years | |
Andrew Shao | M | - | 4 years | |
Avi Mazaltov | M | 62 | 7 years | |
T. Buckley | M | 48 | 23 years | |
John Dillman | M | 56 | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Thomas C. Varvaro | M | 54 | 13 years | |
Alex Worsham | M | - | 5 years | |
Moncef Slaoui | M | 64 | 11 years | |
Stephen R. Allen | M | - | 4 years | |
Troy Allen Rhonemus | M | 51 | 5 years | |
Mark Germain | M | 75 | 16 years | |
Kevin Farr | M | 66 | - | |
Glenn Halpryn | M | 63 | 5 years | |
Daniel Podolsky | M | 70 | 10 years | |
Alex Howarth | M | 55 | 10 years | |
Adam Logal | M | 46 | 3 years | |
Reid Dabney | M | 72 | 9 years | |
Caroline Levy | F | 61 | 1 years | |
Kurt Gustafson | M | 56 | 6 years | |
Christopher McNulty | M | 47 | 5 years | |
Crispin Davis | M | 75 | 10 years | |
Patrick J. T. Vallance | M | 64 | - | |
Mark J. Friedman | M | 66 | 3 years | |
Linda Bain | F | 53 | 1 years | |
Megan Jordan | F | - | - | |
Tsz Ho Lau | M | 34 | 4 years | |
Lisa Harrington | F | 57 | 1 years | |
Tom de Swaan | M | 78 | 9 years | |
Hugh Dunkerley | M | 50 | 14 years | |
Christopher Gent | M | 75 | 11 years | |
Peter Traber | M | 69 | 3 years | |
Michèle Barzach | M | - | 7 years | |
John David Coombe | M | 79 | 5 years | |
Richard Sykes | M | 79 | 7 years | |
Maxine Gowen | M | 66 | 13 years | |
H. Culp | M | 60 | 9 years | |
Deryck Charles Maughan | M | 76 | 12 years | |
Robert Wilson | M | 81 | 11 years | |
Vivid Sehgal | M | 56 | 6 years | |
Brian Blakey | M | 61 | 6 years | |
Christopher Anthony Hogg | M | - | - | |
Will Black | M | 65 | 3 years | |
Matthew Roberts | M | - | 2 years | |
Joseph M. Spagnardi | M | 60 | 11 years | |
Vincent O'Neill | M | 55 | 3 years | |
Peter Goodfellow | M | 72 | 8 years | |
Stewart Mccallum | M | 58 | 9 years | |
Jordan A. Gropack | M | - | 1 years | |
Randall K. Johnson | M | 77 | 20 years | |
Amy Boileau | M | - | 3 years | |
Lisa Bratkovich | F | - | 2 years | |
William D. Smithburg | M | 85 | - | |
Myra Rosario Herrle | M | - | 9 years | |
Joe McCann | M | 47 | 4 years | |
Chao Hong Hu | M | 58 | 1 years | |
Jing Ji | M | 54 | 4 years | |
Monica Viziano | M | 57 | 6 years | |
Robert Copeland | M | - | - | |
Michael Allen Luther | M | 67 | 15 years | |
Donald F. McHenry | M | 87 | - | |
James Wu | M | - | 10 years | |
Lauren Flanagan | F | - | - | |
Lisa Porter | M | 60 | 5 years | |
Gary W. Christianson | M | 69 | 2 years | |
Jennie Younger | F | - | 5 years | |
John B. Ziegler | M | 78 | - | |
F. Roger Hurn | M | 86 | - | |
Howard H. Pien | M | 66 | 12 years | |
Marc Rubin | M | 69 | 13 years | |
Margaret Dalesandro | M | 77 | 2 years | |
Paul Carter | M | 63 | 10 years | |
Tomer Kariv | M | 62 | 1 years | |
John Clarke | M | - | - | |
Ran Nussbaum | M | 51 | 1 years | |
Mark Berger | M | 69 | 5 years | |
Michael Steinmetz | M | 75 |
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | - |
Robert J. DiVasto | M | 68 | 2 years | |
John Hector McArthur | M | 90 | - | |
Denis Brodsky | M | 53 | 5 years | |
Gill Dines | F | - | - | |
Lucy Shapiro | M | 83 | 5 years | |
Paul A. Allaire | M | - | - | |
David Wheadon | M | 66 | 5 years | |
Ryan Dellinger | M | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
United Kingdom | 51 | 51.00% |
United States | 49 | 49.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jeff Baxter
- Personal Network